Therapeutic inertia in diabetes management is the failure to initiate or intensify pharmacological treatment when a patient's glycated hemoglobin (HbA1c) goals are not me [...]

Type 1 diabetes is a medical condition characterized by pancreatic β-cell dysfunction and insulin depletion. Management of type 1 diabetes requires precise injections of [...]

The American Diabetes Association (ADA) established guidelines for HbA1c monitoring to reduce the risk of adverse events in patients with type 2 diabetes mellitus (T2DM). [...]

This dissertation utilized medical record data from 2008 to 2023 from the Harold Schnitzer Diabetes Health Center at Oregon Health & Science University to evaluate th [...]

While youth with elevated HbA1cs are at higher risk of experiencing acute complications, there is less understanding of which social factors are associated with the highe [...]

Diabetes mellitus is a group of metabolic disorders characterized by prolonged elevation of blood glucose levels, inducing numerous complications such [...]

Type 1 diabetes (T1D) is a chronic disease where the pancreas does not produce sufficient insulin. Exogenous insulin is required to be delivered. Over delivery of insulin [...]

An analysis of the publicly available dataset, T1DEXI, focusing on the fat and carbohydrate intake and their impact on glycemic results in type 1 diabetics. Detailed look [...]

In this randomized, three-armed crossover study, we will look at the relationship between carbohydrate and energy intake, and glycemic control, with differing types of ex [...]

Engagement of young adults with Type 1 diabetes (T1D) in a virtual Young Adult Diabetes Clinic as a component of transition from pediatric to adult diabetes care. Young a [...]